Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Times Interest Earned (2019 - 2025)

Kymera Therapeutics (KYMR) has disclosed Times Interest Earned for 7 consecutive years, with -$1087.7 as the latest value for Q4 2025.

  • Quarterly Times Interest Earned rose 20.53% to -$1087.7 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$949.46 through Dec 2025, up 9.64% year-over-year, with the annual reading at -$944.32 for FY2025, 10.13% up from the prior year.
  • Times Interest Earned for Q4 2025 was -$1087.7 at Kymera Therapeutics, down from -$944.09 in the prior quarter.
  • The five-year high for Times Interest Earned was -$371.38 in Q4 2023, with the low at -$1402.7 in Q3 2023.
  • Average Times Interest Earned over 5 years is -$894.97, with a median of -$892.01 recorded in 2021.
  • The sharpest move saw Times Interest Earned surged 43.28% in 2023, then crashed 268.55% in 2024.
  • Over 5 years, Times Interest Earned stood at -$666.55 in 2021, then rose by 1.77% to -$654.75 in 2022, then soared by 43.28% to -$371.38 in 2023, then plummeted by 268.55% to -$1368.7 in 2024, then grew by 20.53% to -$1087.7 in 2025.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$1087.7, -$944.09, and -$782.94 for Q4 2025, Q3 2025, and Q2 2025 respectively.